… Background:Fluorodeoxyglucose positron emission tomography (FDG-PET) is sensitive
for detection of neoplastic solitary pulmonary nodules but may have decreased sensitivity for …

… to evaluate pulmonary neoplasms since its inception. Positron emission tomography (PET) is
… shows great promise for evaluating malignant pulmonary tumors and their metastases. Like …

… neoplastic cells. After intravenous administration, FDG preferentially accumulates within
neoplastic … thorax and reviews the evaluation of focal pulmonary opacities, lung cancer staging, …

… There has been much interest in the high 18FDG uptake in pulmonary neoplasms, where
the tumour/contralateral lung uptake ratio was 6.6 (range 2.7–14.6) in one study [68], and 9.5±…

… (ROC) curve at which positron emission tomography with 18-… in lesions of any size (A)
and in pulmonary nodules (B). … primary neoplasms and in patients with multiple nodules. …

… Moreover, the latter positively contributes to the identification of sub-centimeter pulmonary
neoplasms because their low necrotic areas favor the SUV and thus overall specificity [Citation…

… racic malignancles and suspected pulmonary metastases. … metastases, and to monitor the
therapy of chest neoplasms. … observation that malignant neoplasms show enhanced glucose …

… the diagnostic accuracy of imaging pulmonary lesions, positron emission tomography (PET) …
LH, et al: Glucose utilization in vivo by human pulmonary neoplasms. Cancer 60:2682-2689, …

… Positron emission tomography in patients with glioma: a prediction of prognosis. Cancer …
Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation …

… The form of deoxyglucose labeled with the positron emitter ”F, 2[‘~F]-fluoro-2-deoxy-D-glucose
(FDG), is therefore taken up and retained in normal and neoplastic tissues in proportion to …